Gilead Sciences acquisition of MYR: A strategic move to tackle hepatitis delta virus
In a strategic acquisition aimed at expanding its hepatitis treatment portfolio, US biopharmaceutical giant Gilead Sciences has announced…
Boehringer Ingelheim to acquire NBE-Therapeutics for €1.1bn
Boehringer Ingelheim has entered into a transformative €1.18 billion agreement to acquire NBE-Therapeutics, a clinical-stage biotech company based…
Pfizer and BioNTech’s COVID-19 vaccine secures FDA emergency use authorization
In a groundbreaking move, Pfizer and BioNTech have received emergency use authorization (EUA) from the US Food and…
Pfizer and BioNTech secure Health Canada approval for BNT162b2 Covid-19 vaccine
Pfizer, a leading global pharmaceutical company, and BioNTech, a prominent German biotech firm, have officially secured Health Canada’s…
BetterLife Pharma to acquire Transcend Biodynamics for $10m to advance psychedelic therapeutics
In a move that could significantly impact the psychedelic therapeutics sector, BetterLife Pharma, a Canadian biotech company, has…
Pfizer partners with PostEra to speed up drug discovery using machine learning technology
In an exciting new development, Pfizer has teamed up with PostEra, a leading biotech company specializing in machine…
Alligator Bioscience’s mitazalimab gets FDA approval for clinical trials in US
Swedish biotech company Alligator Bioscience has announced that the US Food and Drug Administration (FDA) has approved its…
PharmaEngine collaborates with Sentinel Oncology for cancer drug development
PharmaEngine, a Taiwanese pharmaceutical company, has entered a strategic collaboration and licensing agreement with UK-based Sentinel Oncology to…
Lilly partners with UnitedHealth Group for pragmatic study of bamlanivimab in high-risk COVID-19 patients
Eli Lilly and Company (Lilly) has formed a strategic collaboration with UnitedHealth Group to conduct a pragmatic clinical…
PTC Therapeutics secures Russian approval for Translarna to treat Duchenne muscular dystrophy
PTC Therapeutics, a leading US-based biotechnology company, has received marketing approval in Russia for its innovative drug, Translarna…